Source:http://linkedlifedata.com/resource/pubmed/id/16745944
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2006-6-5
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/16745944-16577583,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16745944-16744196,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16745944-16745458,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16745944-16745701
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:status |
PubMed-not-MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0264-6021
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2588-603
|
pubmed:dateRevised |
2009-11-18
|
pubmed:year |
1935
|
pubmed:articleTitle |
The reversible inhibition of beta-malt-amylase by ascorbic acid and related compounds.
|
pubmed:affiliation |
The Ontario Research Foundation, Toronto, Canada.
|
pubmed:publicationType |
Journal Article
|